Breadcrumb
About us Our Team
Our Team - Title

Our Team

PeopleCategories
People
JUAN CARLOS HURTADO

JUAN CARLOS HURTADO

Medical Research Fellow Maternal, Child and Reproductive Health

Juan Carlos Hurtado is a medical doctor specialized in infectious diseases and tropical medicine (Perú), and microbiology and parasitology (Spain). He has completed an MSc in translational medicine from the Universitat de Barcelona.


 Currently he works as microbiologist for CaDMIA-plus project at ISGlobal. Additionally, he investigates the application of nanotechnology in the microbiological diagnosis and rapid detection of bacterial antibiotic resistance.


 As ISGlobal faculty member, he collaborates in the courses "Syndromic Diagnosis of the Infectious Diseases" and "Diagnosis of Infections in Immunosupressed Patients" of the Master of Clinical Research: Clinical Microbiology Track.



Lines of research

  •  Clinical microbiology
  •  Antimicrobial resistance
  •  Nanotechnology
  •  HIV/AIDS
  •  Tuberculosis

Main publications

  •  Soto M, Sampietro-Colom L, Vilella A, Pantoja E, Asenjo M, Arjona R, Hurtado JC, Trilla A, Alvarez-Martínez MJ, Mira A, Vila J, Marcos MA. Economic Impact of a New Rapid PCR Assay for Detecting Influenza Virus in an Emergency Department and Hospitalized Patients. PLoS One. 2016 Jan 20;11(1):e0146620
  • Hurtado JC, Martínez MJ. Update on Ebola virus infection. Rev Esp Quimioter. 2015 Sep;28 Suppl 1:43-7
  •  Martínez MJ, Salim AM, Hurtado JC, Kilgore PE. Ebola Virus Infection: Overview and Update on Prevention and Treatment. Infect Dis Ther. 2015 Sep 12. doi: 10.1007/s40121-015-0079-5
  • Hurtado JC, Mosquera MM, de Lazzari E, Martínez E, Torner E, Isanta R et al. Evaluation of a New, Rapid, Simple Test for the Detection of Influenza Virus. BMC Infect Dis. 2015:15 (44) doi: 10.1186/s12879-015-0775-5
  •  Tudo G, Monte MR, Vergara A, Lopez A, Hurtado JC, Ferrer M et al. Implementation of MALDI-TOF Mass Spectometry technology for identification of clinical isolates of Mycobacterium spp. in routine microbiological diagnosis. Eur J Clin Microbiol Infect Dis. 2015:34 (8):1527-32 doi: 10.1007/s10096-015-2381-2
  •  Goepfert PA, Elizaga ML, Seaton K, Tomaras GD, Montefiori DC, Sato A et al. Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles. J Infect Dis. 2014:210 (1):99-110. doi: 10.1093/infdis/jiu003

Asset Publisher